About Trinoveon

Trinoveon Corporation is a Nevada-based, early-stage digital health services company focused on improving patient outcomes and reducing the incidence of vision loss and blindness.  Building on decades of prior experience in clinical eye care and telehealth and digital health technologies in eye care -focused diagnostics, Trinoveon is focused on addressing large unmet needs in the detection, staging and treatment of eye disease, including diabetic retinopathy.  Using its digital health platform, Trinoveon targets big clinical challenges – those where good treatments are available, but the system of care is ineffective and inefficient at delivering them.  By capturing data along the disease management continuum, Trinoveon will develop leading edge analytic tools to optimize management of these diseases.  Its cloud-based platform, along with  other digital diagnostic devices, will enable Trinoveon to extend its applications in other ophthalmic conditions, additional diabetes conditions and target other clinical challenges.